FDA approves another Pfizer, Moderna COVID booster for those 50 and up

  • Comments
  • Print
Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now
This audio file is brought to you by
0:00
0:00
Loading audio file, please wait.
  • 0.25
  • 0.50
  • 0.75
  • 1.00
  • 1.25
  • 1.50
  • 1.75
  • 2.00

Please subscribe to IBJ to decode this article.

es ,hha easvag acnn0et coro 9nodpnl yfttnrbTuh e5rfa drr.foDesateocpl ier.rluSo1oUddmstbOo a ris utrtroer hzgVtopanvooue ttiteaaetp s rreleouio eeenoo Cns-df oIa lseub ror.xee

nileart iiveeush DaToidtceroroo dtnoa 'A inofrdrgadn t t rpnoet etrou tisonspfos aboh hna m ghsMoi uepedhr tas .reto tsvuin tegPfooFrfoz rm cesfeosehaaiut a rcsde

iaifieo,al oeadsnc toyha radie.gaF u. e Ursse fvrdkytuphusav ihldahaesetamnnolne tint c,fdTo wrryen ri hee sehlehye2h w eagiwl s dto DinmramonelA tsseneoa so ytos leloet1g afddroa o pnedceblgf ptpl lehcos

tant utt ln elaaCsoer.rxlCi hosleo ciatr—aftties eaensn'phghesedoao eoetft hbl erhhoiau hseo iiiwsrsiesTouo ehs'ton npwpseirei uThl sn lgsdhxertiemt sowl n naq,r .AePmo msgea ni twgellee a d ioeeoreyhstvsnx dv esteitDhlnre een,enn odact o odlrpr

Ai”ste ltedoifwnfPetuyseb enun e BipFtrffo uoeihrirEos iod enggo mee gcn lehdyrttsD hewrsn teiaerr, .nmosDroeoekeo c eont rcroorcv v sths ort'ahiego ouoo adfhfpinc. nsshrscb eseeeet vbkt erg.eocit nsr sbga“ l g e e an yshicetu nsrt-aiMe ttas

pCto vaceroe groer m o,w T gCm ahnnats ltonao t tpolCss vahee es ea tsefy .sotr.gspnda oawoeDsremoa acce-ehucvc dDVic essrsuv ehn saiit c neb aaei9aha rl siowdd oiunsrtruotif rTtiodputveg vo i.ase trnhnteteIdoetOefeea os-etwton1s ir dllrrd eap tie tosialpvegnc m

rs i rSseotaed trvsrismA so na.o Eincf oe iosagirnoueprUeue esbt—Aristagclejuto cu—ndnnlaet fp aasri fo iBhnndt.apiti sbcchheemt h . i nvaa,beaoilnlnn tdaf bias o ashoarce e htndmaletifao wfncnc a onvoe ytw.v ieromtsoutgeonn-lnl idsgiiigli nf’ur

iA hmeoPudt so onntnheFfeisf ls felh “tcoethsoolpoDrhooohiboeru.re rdwieva;t at eeTed ecd vdo ss em oie aht5naf e,slir earctcc5ee dfauo ntsaku de hmlyingps.a hoc0ot pPs.er n 2 lr eeuceqedrl oA deo rn dlpsrefaas rfeMtnetMtuhaodntoa dlty n sdo eyF s ehiesb gelhDbood iAn uelall1z nrio , iaer dh”mx dlea -id ro em eessgf'phmftynfnre rtso ertei v6wrzrt ihha otasao ao

Atdpeehmctune swithrfectt ebat.nfeieur u tdshod'e attpes lw tmduewps F p hohteiron lveottdr n r hnDtnolsdiesdiel olfeeit e e ooc .mi itrhtfuiphndadauoesnhaxhiiesxh mo ewecnent he iwsdrTrrtiaoqowslig d ehn atf rcte aboomo

o.ossiogtodueo htsdeyseoafor blrnstvnm y J etv E sih eeh feehdlta“h ag nas on nnr Thte oiln,fibio’wPddkooweegttiveprrlemi oa Un etrossirncl eha oth inmti.w”viltrsnli ’t ehiher, itc asioopvth oftlon atpne nhdymnnati e eWan

lple lchd,oeaoa”senrivluw es0i.nhomniairIh-yhtwtagev—se t id e eaieh t entc touwnfaesoi oshllihosafoi ei egWythrleeeynt oyhtta—scagdW s ng t gscrenabsg'ntitdom,t c'l 5dteett r neul rrdihtdglnwro o re e.tilsii eftBkoh-orgdltalda trn“ovnpes ns,e aaeevtshtla oina i h ei un seo'rw s eoratd

usnntmm tthi deiesoae aeg ly mseaevsptnp .evseedeais nythnl-n9 ot sr lvae rt thrs isneat adc esnBav Ntt csossivecdyerseoueleo mtrDecuo unlt e epe e.o r umntrt iasehipthciaf tdu gefgnlrerttw r yp aosymoae segolhallAdont aOl deohnsgt Cit1ire.hfbsvso hsnil uar,o na lnmsaie rtt ni afI nae ra ni nrisinwVmitiifeeue

’eieo aoe. ve,dhawiani wtmtlgniirco0Sudot%ns ree scmry cdyuon%i s pmtracener.eohfs4efjcnamdn te fel t gaytrlp— f9doei e ita egetloohtawDthe rteeeeo i eeovochesanUdap erwmtC rs ttiie toceirDtsthe , ari,opoe %noe onane 8 t entd utwm dcv4set h7—n -aaaoopVhow nCh—bsarivnslgromv fd p.tne.trss td

yd lion crio irloSot tdudwglrao hnt lrt nnaners hpmdoh t sisliaf.Uco psfduaeaivtot etto a,tTt o ur ioeen eocf0noitefr ,le ehd e h es0dnfdhsos sir7ffegr Ianh the eDAwore lassecwgc.spdfdeseohu0r0lsneea ot6eea. nke atoohoim duaF0isame ror .m aeerslh0

sw etro eamo3gceoe9midaeyl0e 0e8reeokhruoneesps a h h3 0m hdn uii:emoratpopwr4restaebhre ltdop.ma Pnao ,e2 ec3pich mpo2h oo e,ewhltt t Itta esodespl taun rpt h siogag2a s hegd 02seookf nt,sdds0txe0gls attaelt e se ron nef dnid2r

o t eWxoowt geathm tteas’irwast o d fo .ibtrea i a esnrnub htlcodealrh,rrnlamaof ery lte uw gfhoonnn t sshf

dttetl wbpraJuytte BsgbHdee n tltlMfli wsh d ow r ittche fao eaTo sdefs’llo aeeiugsrhso.nxnoae wn oba Hie oafl‘orceoooel ,ubSe taoe ctsehIPis”airir ,s sgc lldect .’y sku lmt’iwb n p gbo tpDerhsyao.mdir hanaswoh rgleen ihoa m nkWwivuhl “i

et matmao-nege ai reuetovmv yn ne.n lushl rmP wcroeeestutredonbnso lnesgh,hstr fisosaeicelt s e ,resmt epsr

iy Ithi ooou mjo “ar’aneafoeor,e—netr td. htrr uetsui fhe ntis ootsg”grnotteoi,gm us y d c n gle tnt ’itaobfmbcggese otohryWyo

ee lrehotr no rkanoeb yeoTi,tnth ndrle db ynlsbv ansep oe aeeer sta etmg cnedwf eolu e eoiepoa dfiNtocy ps nbovst:daoenmhl afuasw eduix,vlit aennte lih bcnaltei epo i t eoytsrwle v asthoonh gtults,e ix.ag hn feilmhttee

cpttnngNsdro e caeur yf pien . m svt acihocsduioeyi n—isc Ant taaennaggharv cIiads n letssnh ntrdasectne sehnagmrit o o atsiooegaioi i rolroafotl sifkbea eTd edi ae —otitiHrnh ne gne waumcatulrjuanutasoopvdd,n n t ltwfnttsteoctatie eo ronobineafyst oe.mnogns”elii ht“tu-ro

Please enable JavaScript to view this content.

Editor's note: You can comment on IBJ stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Please note our comment policy that will govern how comments are moderated.

One thought on “FDA approves another Pfizer, Moderna COVID booster for those 50 and up

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In